The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
News |
Patients missing out as industry clinical trial recruitment falls for fifth year in a row
Blog |
What has the higher NICE threshold meant for patients?
News |
New research shows varied access to new medicines across Scotland
News |
Pharmaceutical industry backs Budget move to lift VAT barrier on free-of-charge medicines
Brought Together campaign
The innovative pharmaceutical industry in the UK exists to transform and improve lives through research, development and access to new medicines and vaccines.
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Events
SAVE THE DATE - ABPI Scotland Conference
This conference will bring together government, NHS Scotland, industry, academia and patient organisations to explore how we can turn ABPI Scotland’s Blueprint, into practical action.
The full programme, speaker details and registration information will follow in the coming weeks. In the meantime, please hold the date in your diary.
SAVE THE DATE - ABPI Annual Conference 2027
Save the date for the ABPI Annual Conference 2027, the UK pharmaceutical industry's flagship event bringing together senior leaders, policymakers, clinicians and stakeholders from across the life sciences sector. The conference provides a platform for open dialogue on the issues shaping the future of medicines development, access and innovation in the UK.
Full programme details, speakers and session themes will be announced in due course. Check back for updates, or register your interest to be notified as soon as further information is available.
Over 15,400 NHS patients a year could benefit from new medicines after NICE threshold rise
Early evidence shows that more than 15,400 NHS patients a year could gain access to new medicines they may otherwise have gone without, in just the first five months following a historic change in how NICE values innovation.
Patients missing out as industry clinical trial recruitment falls for fifth year in a row
The number of people taking part in industry clinical trials in the UK has fallen for the fifth year in a row. The ABPI says urgent action is needed.
Economic statistics
£20.39bn
direct Gross Value Added (GVA) [1]
£9.3bn
investment in UK R&D in 2024 [2]
£1 in every £6
invested by the private sector in R&D is invested by the pharmaceutical industry [3]